256 related articles for article (PubMed ID: 16912389)
1. Radiobiological modelling of dose-gradient effects in low dose rate, high dose rate and pulsed brachytherapy.
Armpilia C; Dale RG; Sandilos P; Vlachos L
Phys Med Biol; 2006 Sep; 51(17):4399-411. PubMed ID: 16912389
[TBL] [Abstract][Full Text] [Related]
2. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
[TBL] [Abstract][Full Text] [Related]
3. LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models.
King CR
Brachytherapy; 2002; 1(4):219-26. PubMed ID: 15062170
[TBL] [Abstract][Full Text] [Related]
4. Calculation of integrated biological response in brachytherapy.
Dale RG; Coles IP; Deehan C; O'Donoghue JA
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):633-42. PubMed ID: 9231690
[TBL] [Abstract][Full Text] [Related]
5. Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints.
Lang S; Kirisits C; Dimopoulos J; Georg D; Pötter R
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):619-27. PubMed ID: 17869676
[TBL] [Abstract][Full Text] [Related]
6. Determination of the appropriate fraction number and size of the HDR brachytherapy for cervical cancer.
Liu WS; Yen SH; Chang CH; Yang KM; Wu YP; Chen KY
Gynecol Oncol; 1996 Feb; 60(2):295-300. PubMed ID: 8631555
[TBL] [Abstract][Full Text] [Related]
7. Calculated and simulated effects of heterogeneous dose distributions in radiotherapy using the dose volume inhomogeneity corrected biological equivalent dose formula with special reference to prostate cancer.
Lennernäs B; Albertsson P; Edgren M; Nilsson S
Oncol Rep; 2007 Nov; 18(5):1299-303. PubMed ID: 17914588
[TBL] [Abstract][Full Text] [Related]
8. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity analysis of parameters in linear-quadratic radiobiologic modeling.
Fowler JF
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1532-7. PubMed ID: 19306749
[TBL] [Abstract][Full Text] [Related]
10. Pulsed dose rate and fractionated high dose rate brachytherapy: choice of brachytherapy schedules to replace low dose rate treatments.
Visser AG; van den Aardweg GJ; Levendag PC
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):497-505. PubMed ID: 8567354
[TBL] [Abstract][Full Text] [Related]
11. Radiobiological equivalent of low/high dose rate brachytherapy and evaluation of tumor and normal responses to the dose.
Manimaran S
Radiat Med; 2007 Jun; 25(5):229-35. PubMed ID: 17581712
[TBL] [Abstract][Full Text] [Related]
12. Values of biologically equivalent doses in healthy tissues: comparison of PDR and HDR brachytherapy techniques.
Skowronek J; Malicki J; Piotrowski T
Brachytherapy; 2010; 9(2):165-70. PubMed ID: 19879813
[TBL] [Abstract][Full Text] [Related]
13. Comparison of PDR brachytherapy and external beam radiation therapy in the case of breast cancer.
Teymournia L; Berger D; Kauer-Dorner D; Poljanc K; Seitz W; Aiginger H; Kirisits C
Phys Med Biol; 2009 Apr; 54(8):2585-95. PubMed ID: 19349657
[TBL] [Abstract][Full Text] [Related]
14. [Theoretical considerations of dose-rate effect for clinical application: a study of pulsed brachytherapy].
Shigematsu N; Ito H; Kubo A; Dokiya T
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Jul; 56(8):595-8. PubMed ID: 8797352
[TBL] [Abstract][Full Text] [Related]
15. [The radiobiology of gynecologic HDR and LDR afterloading technics].
Bauer M; Schulz-Wendtland R
Rontgenblatter; 1989 Jan; 42(1):54-6. PubMed ID: 2645638
[TBL] [Abstract][Full Text] [Related]
16. Quality of interstitial PDR-brachytherapy-implants of head-and-neck-cancers: predictive factors for local control and late toxicity?
Melzner WJ; Lotter M; Sauer R; Strnad V
Radiother Oncol; 2007 Feb; 82(2):167-73. PubMed ID: 17258340
[TBL] [Abstract][Full Text] [Related]
17. The implementation of the Gynaecological Groupe Européen de Curiethérapie - European Society for Therapeutic Radiology and Oncology radiobiology considerations in the conversion of low dose rate to pulsed dose rate treatment schedules for gynaecological brachytherapy.
Baker S; Pooler A; Hendry J; Davidson S
Clin Oncol (R Coll Radiol); 2013 Apr; 25(4):265-71. PubMed ID: 23218875
[TBL] [Abstract][Full Text] [Related]
18. The linear-quadratic model and most other common radiobiological models result in similar predictions of time-dose relationships.
Brenner DJ; Hlatky LR; Hahnfeldt PJ; Huang Y; Sachs RK
Radiat Res; 1998 Jul; 150(1):83-91. PubMed ID: 9650605
[TBL] [Abstract][Full Text] [Related]
19. Head and neck brachytherapy.
Mazeron JJ; Noël G; Simon JM
Semin Radiat Oncol; 2002 Jan; 12(1):95-108. PubMed ID: 11813154
[TBL] [Abstract][Full Text] [Related]
20. The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate.
Sminia P; Schneider CJ; Fowler JF
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):844-9. PubMed ID: 11849810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
